Similar to our results, Fang and colleagues (2019) identified the downregulation of Camk2a in the hippocampus proteome of AD patients, but its expression level was not significantly altered in the pre-frontal cortex [52]. This evidence concerns the gene CAMK2A and Alzheimer disease.